Overview


According to FutureWise analysis the market for Hard HPMC Capsule in 2023 is US$ 1.72 billion, and is expected to reach US$ 2.96 billion by 2031 at a CAGR of 7.02%.

HPMC capsules are dietary supplements made from plant-based ingredients. The main ingredient in hard HPMC capsules is cellulose, which is a carbohydrate found in plant cell walls. Known as vegetable capsules, hard HPMC capsules are made from pullulan, a type of polymer derived from starch. They are commonly used as alternatives to gelatin capsules because they are vegan friendly. An algae-derived dietary fiber, carrageenan contains a number of health benefits. It is commonly used as an additive and thickener in food. There is no nutritional value to carrageenan, and it is not digested by the body. Many processed foods contain carrageenan, such as dairy products, infant formula, ice cream, chocolate milk, cottage cheese, sour cream, yogurt, whipped cream, deli meats, and canned soups. In addition to toothpaste and mouthwash, carrageenan is also used in some products. There is a wide range of uses for hard HPMC capsules in the pharmaceutical industry, including solid oral dosage forms, enteric coatings, and controlled release formulations. There are many advantages to using hard capsules over other oral solid dosage forms, such as better bioavailability, better patient compliance, and enhanced stability. Furthermore, hard capsules can be designed to target specific areas of the gastrointestinal tract for drug delivery. As an excipient in pharmaceutical formulations, hard capsules are also commonly used. In the nutraceutical industry, hard HPMC capsules are widely used due to their superior properties, such as better stability, longer shelf life, and ease of swallowing. Hard HPMC capsules are preferred over tablets and powders because of their higher bioavailability. Vitamins, minerals, amino acids, and herbs are commonly delivered in hard HPMC capsules. Food manufacturers use hard HPMC capsules for oral solid dosage forms, enteric coatings, and controlled release applications. Oral solid dosage forms such as hard capsules offer many advantages over other forms, including improved bioavailability, better patient compliance, and enhanced stability. Additionally, hard capsules can be designed to target specific areas of the gastrointestinal tract. It is also common for hard capsules to be used in the formulation of foods.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Hard HPMC Capsule Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Hard HPMC Capsule Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Capsugel
  • Qualicaps LLC
  • CapsCanada
  • ACG Worldwide
  • Sunil Healthcare Ltd
  • Bright Pharma Caps Inc
  • Suheung Co., Ltd
  • BioCaps Enterprise Inc
  • HealthCaps India Ltd
  • Baotao Capstech Co., Ltd
  • Wuhan Carma Technology Co., Ltd.
  • Shanghai Honest Chemical Co., Ltd
  • Strohcaps Inc
  • Shaoxing Kangke Capsule Co., Ltd
  • Zhejiang Yuexi Capsule Co. Ltd
  • GS Capsule

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Carrageenan
  • Gellan Gum
  • Pectin
  • Glycerin
  • Others

By Application

  • Pharmaceutical
  • Nutraceutical
  • Food
  • Cosmetics
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Hard HPMC Capsule Market By Product Type, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Hard HPMC Capsule Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Hard HPMC Capsule Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Hard HPMC Capsule Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Hard HPMC Capsule Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Carrageenan
        2. Gellan Gum
        3. Pectin
        4. Glycerin
        5. Others

  • 8.   Hard HPMC Capsule Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical
        2. Nutraceutical
        3. Food
        4. Cosmetics
        5. Others

  • 9.   Hard HPMC Capsule Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Others

  • 10.   North America Hard HPMC Capsule Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Hard HPMC Capsule Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Hard HPMC Capsule Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Hard HPMC Capsule Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Hard HPMC Capsule Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Capsugel
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Qualicaps LLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. CapsCanada
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. ACG Worldwide
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sunil Healthcare Ltd
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bright Pharma Caps Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Suheung Co., Ltd
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. BioCaps Enterprise Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. HealthCaps India Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Baotao Capstech Co., Ltd
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Wuhan Carma Technology Co., Ltd.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Shanghai Honest Chemical Co., Ltd
         12.1. Company Overview
         12.2. Product Portfolio
            12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Strohcaps Inc
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Shaoxing Kangke Capsule Co., Ltd
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Zhejiang Yuexi Capsule Co. Ltd
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. GS Capsule
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients